Garnier-Crussard, Antoine
Article History
Received: 3 January 2024
Accepted: 26 July 2024
First Online: 1 August 2024
Declarations
:
: Not applicable.
: Not applicable.
: Independent of this work, AGC is an unpaid sub-investigator or principal investigator Alzheimer’s disease clinical trials: NCT04867616 (UCB Pharma), NCT04241068 (Biogen), NCT05310071 (Biogen), NCT03446001 (TauRx Therapeutics), NCT03444870 (Roche), NCT04374253 (Roche), NCT04777396 (Novo Nordisk), NCT04777409 (Novo Nordisk), NCT04770220 (Alzheon), NCT05423522 (Medesis Pharma).